You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Quick Magnetic Analgesia Cuff

    SBC: Cornerstone Research Group, Incorporated            Topic: DHA191011

    Cornerstone Research Group Inc. (CRG) proposes to develop an externally wearable, non-invasive, battery-operated device capable of providing analgesia equivalent to pharmacological peripheral ring nerve blocks by manipulating nervous system activity with

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  2. POC Blood Coagulopathy Monitor

    SBC: CFD Research Corporation            Topic: DHA19A001

    Traumatic injuries account for 30% of all life years lost in the US and is the leading cause of death for people under 46 years of age. Uncontrolled bleeding or hemorrhage constitute 30-40% of trauma related deaths and are considered to be a major cause o

    STTR Phase I 2019 Department of DefenseDefense Health Program
  3. Augmented Reality Surgical Visualization

    SBC: CFD Research Corporation            Topic: DHA191001

    Care for the wounded Warfighters in austere and remote settings makes medical knowledge, skills and efficiency of the military medical professional paramount. For wounds that extend deep into internal anatomy, proper visualization of internal anatomy can

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  4. Advanced Simulated Patient Intelligent Response Engine (ASPIRE)

    SBC: Vcom3D, Inc.            Topic: DHA191002

    The goal of medical simulation-based training such as high-fidelity manikin simulators, part task trainers, and screen-based virtual patients, is to approximate real-life treatment experiences without risk to live patients. While the use of sensors has ma

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  5. ReMIDe (Reliable Medical Information Delivery in DIL environments)

    SBC: Architecture Technology, Inc.            Topic: DHA191004

    The Defense Health Agency has identified the need for an advanced computing and networking capability to support unfettered operation of Electronic Medical Records (EMR) systems in delayed/disconnected, intermittently-connected, low-bandwidth (DIL) enviro

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  6. Ruggedized Inertial Measurement Unit System to Assess Movement Dysfunction in Austere Environments

    SBC: APDM, INC.            Topic: DHA191010

    Current balance and gait assessment practices in field environments lack adequate sensitivity to measure subtle but potentially duty-limiting deficits in Service Member (SM) performance. Clinicians endeavor to provide timely, evidence-based assessment of

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  7. Cervical Spine Health Improvement Products

    SBC: Switchbox, Inc.            Topic: DHA18B001

    Most standard-of-care tools and techniques for evaluating neck disorders are subjective, unreliable, and do not provide actionable information for providers, payers, and organizations to deliver efficient and effective care. This lack of objective neck he

    STTR Phase I 2019 Department of DefenseDefense Health Program
  8. Field Portable Mass Spectrometry for Small Molecule Drugs in Clinical Samples

    SBC: Spectral Energies, LLC            Topic: CBD181006

    We propose a novel two-dimensional mass spectrometry (2D-MS) technique based on ion trap arrays to identify illicit and designer drugs. This approach will give an unprecedented multiplex advantage for miniature mass spectrometry, allowing novice field technicians to rapidly identify drugs affecting the central nervous system based on both the m/z ratio and fragmentation pattern of an ion. Towards ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  9. Dual Formulation of Atropine/Scopolamine with Enhanced Stability

    SBC: Cmc Pharmaceuticals, Inc.            Topic: CBD181005

    CMC Pharmaceuticals, Inc. (Cleveland, OH) is proposing developing a stable, combination product of two small molecule drug candidates as a counter measure to chemical warfare nerve agents (NA). The combination product is expected to exploit complementary pharmacological profiles for optimal muscarinic receptor blockade and anticholinergic activity within the peripheral and central nervous system. ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  10. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government